Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying study information.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision: v3.5.2 has been introduced, replacing the previous v3.5.0.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; this appears to be a minor maintenance/feature update with no changes to study content or user-facing functionality.SummaryDifference0.0%

- Check52 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded the disease tag Gastric cancer and a Resources link to the Genetic and Rare Diseases Information Center. Updated page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check80 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.